Planning

Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine

ANIMAL AND PLANT HEALTH AGENCY

This public procurement record has 2 releases in its history.

Planning

08 Aug 2025 at 07:56

UK2 - Preliminary Market Engagement Notice
Planning

07 Aug 2025 at 15:17

UK1 - Pipeline Notice
Summary of the contracting process

The procurement process is initiated by the Animal and Plant Health Agency as the buying organisation, alongside the Department of Environment, Food and Rural Affairs serving as the procuring entity. This tender involves the purchase, storage, and emergency production of Foot and Mouth Disease antigen and vaccine, falling under the goods industry category related to vaccines for veterinary medicine. Located in London, UK, the process is currently in the Planning stage with a focus on market engagement. Key dates include the submission of relevant supplier information by 8th September 2025, with a contract period planned from 1st April 2026 to 31st December 2031, and a renewal option extending to 31st December 2036. The available budget for this procurement is approximately £4,500,000, highlighting a significant emphasis on ensuring a reliable supply of vaccines, under a public authority, central government classification.

This tender presents substantial opportunities for businesses involved in the veterinary medicine sector, especially those capable of producing and supplying vaccines with proven quality, safety, and efficacy, to expand their footprint. The planned procurement process provides a promising platform for small and medium-sized enterprises (SMEs) given its suitability criteria that favour such entities. Companies with existing infrastructure for foot and mouth vaccine production, storage, and distribution could benefit greatly. The procurement method encourages market engagement, which could lead to direct business with Defra, offering long-term contract potential and enhancing business growth through public sector collaboration.

Find more tenders on our Open Data Platform.
How relevant is this notice?

Notice Information

Notice Title

Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine

Notice Description

Defra is exploring options for supply of antigen and vaccines to the UK foot and mouth disease (FMD) vaccine bank and is seeking to identify existing and potential suppliers who have FMD vaccines with robust evidence of quality, safety, and efficacy. We are keen to hear from suppliers who are in a position to supply suitable FMD vaccine products from early 2027 (including manufacturing lead times as necessary). Please provide the information detailed in the section below, but please note that Defra will not consider heterologous vaccine products. Those wishing to provide the information requested here should contact Melanie Swain (melanie.swain@defra.gov.uk), by the 8 September 2025. Defra reserves the right to follow up with suppliers on a 1:1 basis to further understand their capabilities with regard to this requirement. Defra is seeking this information to inform decisions around guarantees of supply to the UK market. Therefore the estimated total value shown below is only indicative at this stage.

Planning Information

If your organisation is interested in this requirement, please provide the following information to the named contact above, via email: - The details of your organisation's FMD antigen and vaccine products. - Number and size of dose. - Data on safety, efficacy and period (onset and duration) of immunity in the target species. - Longevity/shelf life of vaccines and antigen. - The number of doses in the vaccination schedule. - Storage conditions and bottle sizes available. - The type of technology used to develop the vaccine production capacity. - Species that can be vaccinated and any data on the minimum age that animals can be vaccinated. - Whether the vaccine is produced to GMP standard or equivalent. - Whether the vaccine is manufactured and stored according to the WOAH Terrestrial Manual Chapter 3.1.8. - Whether the vaccine is currently authorised for use with a valid marketing authorisation and, if so, where is the vaccine authorised. - Whether the vaccine has been used elsewhere in the world. - Timelines for submitting applications for a marketing authorisation to VMD (if relevant). - The likely cost of the product. - Information on novel technologies and products and likely timeframe to market.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0583a6
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/047118-2025
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651690 - Vaccines for veterinary medicine

Notice Value(s)

Tender Value
£4,500,000 £1M-£10M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
8 Aug 20258 months ago
Submission Deadline
Not specified
Future Notice Date
21 Nov 2025Expired
Award Date
Not specified
Contract Period
31 Mar 2026 - 31 Dec 2031 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
ANIMAL AND PLANT HEALTH AGENCY
Additional Buyers

DEPARTMENT OF ENVIRONMENT, FOOD AND RURAL AFFAIRS

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SW1P 4DF
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
Westminster
Electoral Ward
St James's
Westminster Constituency
Cities of London and Westminster

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0583a6-2025-08-08T08:56:20+01:00",
    "date": "2025-08-08T08:56:20+01:00",
    "ocid": "ocds-h6vhtk-0583a6",
    "initiationType": "tender",
    "planning": {
        "documents": [
            {
                "id": "047030-2025",
                "documentType": "plannedProcurementNotice",
                "noticeType": "UK1",
                "description": "Pipeline notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/047030-2025",
                "datePublished": "2025-08-07T16:17:58+01:00",
                "format": "text/html"
            },
            {
                "id": "047118-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/047118-2025",
                "datePublished": "2025-08-08T08:56:20+01:00",
                "format": "text/html"
            }
        ],
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "If your organisation is interested in this requirement, please provide the following information to the named contact above, via email: - The details of your organisation's FMD antigen and vaccine products. - Number and size of dose. - Data on safety, efficacy and period (onset and duration) of immunity in the target species. - Longevity/shelf life of vaccines and antigen. - The number of doses in the vaccination schedule. - Storage conditions and bottle sizes available. - The type of technology used to develop the vaccine production capacity. - Species that can be vaccinated and any data on the minimum age that animals can be vaccinated. - Whether the vaccine is produced to GMP standard or equivalent. - Whether the vaccine is manufactured and stored according to the WOAH Terrestrial Manual Chapter 3.1.8. - Whether the vaccine is currently authorised for use with a valid marketing authorisation and, if so, where is the vaccine authorised. - Whether the vaccine has been used elsewhere in the world. - Timelines for submitting applications for a marketing authorisation to VMD (if relevant). - The likely cost of the product. - Information on novel technologies and products and likely timeframe to market.",
                "dueDate": "2025-09-08T23:59:59+01:00",
                "status": "scheduled"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-PPON-PBHC-6261-BLLQ",
            "name": "ANIMAL AND PLANT HEALTH AGENCY",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PBHC-6261-BLLQ"
            },
            "address": {
                "streetAddress": "Seacole Building, 2 Marsham Street",
                "locality": "London",
                "postalCode": "SW1P 4DF",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI32"
            },
            "contactPoint": {
                "name": "Melanie Swain",
                "email": "melanie.swain@defra.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://defra-family.force.com/s/Welcome",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    }
                ]
            }
        },
        {
            "id": "GB-PPON-PNBD-3289-CDGX",
            "name": "DEPARTMENT OF ENVIRONMENT, FOOD AND RURAL AFFAIRS",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PNBD-3289-CDGX"
            },
            "address": {
                "streetAddress": "Seacole Building, 2 Marsham Street",
                "locality": "London",
                "postalCode": "SW1P 4DF",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI32"
            },
            "contactPoint": {
                "name": "Melanie Swain",
                "email": "melanie.swain@defra.gov.uk"
            },
            "roles": [
                "procuringEntity"
            ],
            "roleDetails": "Defra Group Commercial",
            "details": {
                "url": "https://defra-family.force.com/s/Welcome"
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PBHC-6261-BLLQ",
        "name": "ANIMAL AND PLANT HEALTH AGENCY"
    },
    "tender": {
        "id": "P37007",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine",
        "description": "Defra is exploring options for supply of antigen and vaccines to the UK foot and mouth disease (FMD) vaccine bank and is seeking to identify existing and potential suppliers who have FMD vaccines with robust evidence of quality, safety, and efficacy. We are keen to hear from suppliers who are in a position to supply suitable FMD vaccine products from early 2027 (including manufacturing lead times as necessary). Please provide the information detailed in the section below, but please note that Defra will not consider heterologous vaccine products. Those wishing to provide the information requested here should contact Melanie Swain (melanie.swain@defra.gov.uk), by the 8 September 2025. Defra reserves the right to follow up with suppliers on a 1:1 basis to further understand their capabilities with regard to this requirement. Defra is seeking this information to inform decisions around guarantees of supply to the UK market. Therefore the estimated total value shown below is only indicative at this stage.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651690",
                        "description": "Vaccines for veterinary medicine"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 5400000,
            "amount": 4500000,
            "currency": "GBP"
        },
        "mainProcurementCategory": "goods",
        "aboveThreshold": true,
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2026-04-01T00:00:00+01:00",
                    "endDate": "2031-12-31T23:59:59Z",
                    "maxExtentDate": "2036-12-31T23:59:59Z"
                },
                "hasRenewal": true,
                "status": "planned"
            }
        ],
        "communication": {
            "futureNoticeDate": "2025-11-21T23:59:59Z"
        },
        "status": "planned"
    },
    "language": "en"
}